Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Josh Neman, PhD
NeOnc Technologies Holdings, Inc.
Study Director - Thomas Chen, MD, PhD
NeOnc Technologies Holdings, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California
Los Angeles, California, United States
Frances Chow, MDRecruiting - Saint John Cancer Institute
Santa Monica, California, United States
Naveed Wagle, MDRecruiting - Georgia Cancer Center (augusta University)
Augusta, Georgia, United States
Gerald WallaceRecruiting - Ochsner Health
New Orleans, Louisiana, United States
Caroline GoldinRecruiting - Atlantic Health (overlook Medical Center)
Summit, New Jersey, United States
Robert AikenRecruiting - Northwell Health
New York, New York, United States
Samuel SingerRecruiting - Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Recruiting - Cleveland Clinic
Cleveland, Ohio, United States
David Peereboom, MDRecruiting - Baylor Scott & White Health
Dallas, Texas, United States
Recruiting - University of Texas Southwestern Medical Center
Dallas, Texas, United States
Recruiting - University of Washington Medical Center
Seattle, Washington, United States
Not, yet, recruiting - University of Wisconsin Hospital and Clinic
Madison, Wisconsin, United States
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2017
- Primary completion
- 30 Mar 2026
- Completion
- 30 Jun 2026
- Last update posted
- 2 Mar 2026
- Registered enrollment
- 49
- Registry id
- NCT02704858
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.